256 results
Page 8 of 13
6-K
EX-99.2
6x20pg54990
16 Aug 21
Interim Consolidated Financial Statements
12:00am
6-K
EX-99.1
uao8gitj cporp2m
4 Aug 21
SciSparc Announces Completion of Corporate Rebranding and Launch of New Website
4:44pm
6-K
EX-99.1
r2xsbx
28 Jul 21
SciSparc Announces Updates Regarding its Phase IIb Study in Tourette Syndrome
4:00pm
6-K
EX-99.1
d3nhrj52rdt7bz
7 Jul 21
Current Report of Private Issuer
4:00pm
F-1/A
2rr1fypn
28 Apr 21
Registration statement (foreign) (amended)
4:38pm
F-1
ngu8yk oeo8
21 Apr 21
Registration statement (foreign)
4:17pm
POS AM
thblm
31 Mar 21
Prospectus update (post-effective amendment)
12:00am
POS AM
4dzwyz32d li3qhufix
31 Mar 21
Prospectus update (post-effective amendment)
12:00am
6-K
EX-99.3
vipsw5vc
2 Mar 21
Report of Foreign Private Issuer
4:05pm
6-K
EX-99.2
jqsdnll
2 Mar 21
Report of Foreign Private Issuer
4:05pm
6-K
EX-99.1
yb0u92cnk
24 Feb 21
SciSparc Corporate Presentation February 2021
9:27am
6-K
EX-99.1
dnv3du24
17 Feb 21
Report of Foreign Private Issuer
8:35am
6-K
EX-99.1
3hcx3m7
11 Feb 21
SciSparc Announces Rebranding and Business Updates
10:01am
6-K
EX-99.1
fwp m2sn4lp4f13jil5
10 Feb 21
SciSparc Engages Procaps for Development and Production of CannAmideā¢ and its SCI-110 Product Candidate
8:33am
6-K
EX-99.1
1zosiyp oio3
9 Feb 21
SciSparc Initiates Commercial Production of its CannAmideā¢ Pills
8:36am
6-K
EX-99.1
fpyzwm
28 Jan 21
Report of Foreign Private Issuer
9:36am
6-K
EX-99.1
ys28egjok4qu82gbrr3
25 Jan 21
Special General Meeting of Shareholders
5:27pm
6-K
EX-99.1
vn3jrxzybe y56l
5 Jan 21
Therapix Biosciences and Cyntar Ventures Entered a Non-Binding Letter of Intent for the Distribution of TheraPEA in Canada
9:12am